The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Recent advances in pulmonary drug delivery using large, porous inhaled particles
Abstract
The ability to deliver proteins and peptides to the systemic circulation by inhalation has contributed to a rise in the number of inhalation therapies under investigation. For most of these therapies, aerosols are designed to comprise small spherical droplets or particles of mass density near 1 g/cm 3 and mean geometric diameter between ∼1 and 3 μm, suitable for particle penetration into the airways or lung periphery. Studies performed primarily with liquid aerosols have shown that these characteristics of inhaled aerosols lead to optimal therapeutic effect, both for local and systemic therapeutic delivery. Inefficient drug delivery can still arise, owing to excessive particle aggregation in an inhaler, deposition in the mouth and throat, and overly rapid particle removal from the lungs by mucocilliary or phagocytic clearance mechanisms. To address these problems, particle surface chemistry and surface roughness are traditionally manipulated. Recent data indicate that major improvements in aerosol particle performance may also be achieved by lowering particle mass density and increasing particle size, since large, porous particles display less tendency to agglomerate than (conventional) small and nonporous particles. Also, large, porous particles inhaled into the lungs can potentially release therapeutic substances for long periods of time by escaping phagocytic clearance from the lung periphery, thus enabling therapeutic action for periods ranging from hours to many days.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Large Porous Particles for Pulmonary Drug Delivery
Edwards, D. A., Hanes, J., Caponetti, G., Hrkach, J., Ben-Jebria, A., Eskew, M. L., Mintzes, J., Deaver, D., Lotan, N., & Langer, R. (1997) · Science · doi:10.1126/science.276.5320.1868 · Cited by 1,174
Self-citationMechanisms of macromolecule absorption by the lungs
Patton, J. S. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00113-l · Cited by 641
Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage
Tabata, Y., & Ikada, Y. (1988) · Biomaterials · doi:10.1016/0142-9612(88)90033-6 · Cited by 538
Respiratory Drug Delivery (1989)
Byron, P. R. (2018) · CRC Press eBooks · doi:10.4324/9780203710456 · Cited by 449
Drug delivery to the respiratory tract using dry powder inhalers
Timsina, M. P., Martin, G. P., Marriott, C., Ganderton, D., & Yianneskis, M. (1994) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)90070-1 · Cited by 325
On the removal of air-borne droplets by the human respiratory tract: I. The lung
Landahl, H. D. (1950) · The Bulletin of Mathematical Biophysics · doi:10.1007/bf02477345 · Cited by 280
Tabata, Y., & Ikada, Y. (1988) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820221002 · Cited by 235
Inhalation Studies: Foundations and Techniques
Kutzman, R. S. (1984) · Environmental Health Perspectives · doi:10.1289/ehp.58-1569427 · Cited by 228
Polymer-controlled drug delivery systems
Langer, R. (1993) · Accounts of Chemical Research · doi:10.1021/ar00034a004 · Cited by 210
Self-citationCalculated deposition of inhaled particles in the airway generations of normal subjects
Gerrity, T. R., Lee, P. S., Hass, F. J., Marinelli, A., Werner, P., & Lourenco, R. V. (1979) · Journal of Applied Physiology · doi:10.1152/jappl.1979.47.4.867 · Cited by 180
Cited by
Pharmaceutical Particle Engineering via Spray Drying
Vehring, R. (2008) · Pharmaceutical Research · doi:10.1007/s11095-007-9475-1 · Cited by 1,691
Inhaling medicines: delivering drugs to the body through the lungs
Patton, J. S., & Byron, P. R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2153 · Cited by 1,331
Mundargi, R. C., Babu, V. R., Rangaswamy, V., Patel, P., & Aminabhavi, T. M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.09.013 · Cited by 1,025
Violent expiratory events: on coughing and sneezing
Bourouiba, L., Dehandschoewercker, E., & Bush, J. W. M. (2014) · Journal of Fluid Mechanics · doi:10.1017/jfm.2014.88 · Cited by 828
Inhaled nanoparticles—A current review
Yang, W., Peters, J. I., & Williams, R. O. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.02.011 · Cited by 666
Non-invasive delivery strategies for biologics
Anselmo, A. C., Gokarn, Y., & Mitragotri, S. (2019) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.183 · Cited by 665
Nanoparticles for drug delivery to the lungs
Sung, J. C., Pulliam, B. L., & Edwards, D. A. (2007) · Trends in Biotechnology · doi:10.1016/j.tibtech.2007.09.005 · Cited by 643
Self-citationTherapeutic applications of lipid-coated microbubbles
Unger, E. C., Porter, T., Culp, W., Labell, R., Matsunaga, T., & Zutshi, R. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.006 · Cited by 591
Particle Size Analysis in Pharmaceutics: Principles, Methods and Applications
Shekunov, B. Y., Chattopadhyay, P., Tong, H. H. Y., & Chow, A. H. L. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9146-7 · Cited by 545
An overview of clinical and commercial impact of drug delivery systems
Anselmo, A. C., & Mitragotri, S. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.053 · Cited by 520
Microparticles and nanoparticles for drug delivery
Kohane, D. S. (2007) · Biotechnology and Bioengineering · doi:10.1002/bit.21301 · Cited by 517
Advances in nanomaterial-based targeted drug delivery systems
Cheng, X., Xie, Q., & Sun, Y. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1177151 · Cited by 395
Update on Macrophage Clearance of Inhaled Micro- and Nanoparticles
Geiser, M. (2010) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2009.0797 · Cited by 365
Evolution of dry powder inhaler design, formulation, and performance
NEWMAN, S. P., & BUSSE, W. W. (2002) · Respiratory Medicine · doi:10.1053/rmed.2001.1276 · Cited by 340
Alternative routes of insulin delivery
Owens, D. R., Zinman, B., & Bolli, G. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.01076.x · Cited by 332
Materials and methods for delivery of biological drugs
Zelikin, A. N., Ehrhardt, C., & Healy, A. M. (2016) · Nature Chemistry · doi:10.1038/nchem.2629 · Cited by 315
Schneider, C. S., Xu, Q., Boylan, N. J., Chisholm, J., Tang, B. C., Schuster, B. S., Henning, A., Ensign, L. M., Lee, E., Adstamongkonkul, P., et al. (2017) · Science Advances · doi:10.1126/sciadv.1601556 · Cited by 311
Technological and practical challenges of dry powder inhalers and formulations
Hoppentocht, M., Hagedoorn, P., Frijlink, H. W., & de Boer, A. H. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.04.004 · Cited by 303
Dry powder inhalers (DPIs)—A review of device reliability and innovation
Islam, N., & Gladki, E. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.04.044 · Cited by 298
Mangal, S., Gao, W., Li, T., & Zhou, Q. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.34 · Cited by 288
Ruge, C. A., Kirch, J., & Lehr, C.-M. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70072-9 · Cited by 280
Development of highly porous large PLGA microparticles for pulmonary drug delivery
Yang, Y., Bajaj, N., Xu, P., Ohn, K., Tsifansky, M. D., & Yeo, Y. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.12.044 · Cited by 266
Dry powder inhalers for pulmonary drug delivery
Frijlink, H. W., & De Boer, A. H. (2004) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.1.1.67 · Cited by 259
PLGA–PEI nanoparticles for gene delivery to pulmonary epithelium
Bivas-Benita, M., Romeijn, S., Junginger, H. E., & Borchard, G. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.03.008 · Cited by 256
Koushik, K., & Kompella, U. B. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000019308.25479.a4 · Cited by 86
“5 g/cm(3) and mean geometric diameters (d) of <5 m adsorbed onto carrier particles to facilitate deep lung deposition (8).”
BackgroundAerosolized nanostructured itraconazole as prophylaxis against invasive pulmonary aspergillosis
Alvarez, C. A., Wiederhold, N. P., McConville, J. T., Peters, J. I., Najvar, L. K., Graybill, J. R., Coalson, J. J., Talbert, R. L., Burgess, D. S., Bocanegra, R., et al. (2007) · Journal of Infection · doi:10.1016/j.jinf.2007.01.014 · Cited by 43
Encapsulation of PROLI/NO in biodegradable microparticles
Jeh, H. S., Lu, S., & George, S. C. (2004) · Journal of Microencapsulation · doi:10.1080/02652040310001619767 · Cited by 20
Metadata
- Authors
- Edwards, D. A., Ben-Jebria, A., & Langer, R.
- Venue
- Journal of Applied Physiology
- Publisher
- American Physiological Society
- Published
- 1998-08-01
- Volume
- 85
- Issue
- 2
- Pages
- 379-385
- ISSN
- 0161-7567 (ISSN-L)
- 8750-7587
- 1522-1601
- OpenAlex
- W2273327004
- Cited by
- 341
- References
- 25
- FWCI
- 3.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.